RE:Orders for LABS from 'large traditional global pharma subaru1i wrote: partner'??? Did their large traditional global pharmaceutical partner give LABS cannabinoid molecule production orders in Q4, 2023????????????????????????????????????????????????????
The FDA did say publicly that cannabinoids have application in a variety of human ailments including CANCER.
Well for the FDA to make that claim publicly they had to have the SCIENTIFIC EVIDENCE and CLINICAL TRIAL DATA to make that statement publicly and with LABS being the ONLY FDA approved source for pharmaceutical cannabinoids then it points to the scientific evidence and clincial data coming from cannabinoid pharmaceutical supplied by LABS and LABS did say they had over 20 strong clinical trials and most importantly when released publicly in the past, it too was said...MANY IN LATE STAGE.
So just wondering, did LABS receive any material orders from their global pharmaceutical partner??
When you connect the facts and knowledge base associated with LABS, it is then very possible that my question comes with a great deal of gravity.
One has to look carefully when at their financial cross roads...intended for those thinking the stock market is a casino game on their smart phone.
Have a nice night and if short, try not to have a tummy ache.
come on Subaru1i you know better than that, you say your a smart guy!!!//
"Well for the FDA to make that claim publicly they had to have the SCIENTIFIC EVIDENCE and CLINICAL TRIAL DATA to make that statement publicly and with LABS being the ONLY FDA approved source for pharmaceutical cannabinoids then it points to the scientific evidence and clincial data coming from cannabinoid pharmaceutical supplied by LABS and LABS did say they had over 20 strong clinical trials and most importantly when released publicly in the past, it too was said...MANY IN LATE STAGE." the scientific evidence you mention does not only have to come from Trial Data conducted in the US...there are many Trials all across the world being conducted and as long as these trials adhere to FDA regulations a company or the FDA can say that there is evidence that a drug/treatment works.
if a company operating out of lets say England or Europe conducts all their trials overseas as long as these trials adhere to FDA standards the company can use the results of the trials to then ask for FDA aproval for the drug and i guess the FDA could site these trials as evidence of efficacy of a treatment or drug. even if said company they initially aplied for aproval overseas.
the cost and time it would take for a drug manufacturer to conduct trials in each country that they would want aproval for would be prohibitive. no need to come up with these kind of scanarios to make LABS look better than they already are.
now i would agree that if someone wanted to run a study or trial in the US and want the FDA aprove the results they would have to use LABS as their suplier as all ingrediance in such a drug or things used in a trial would need FDA/ regulatory aproval.